ArticleScientific reports2016

Potent response of QS-21 as a vaccine adjuvant in the skin when delivered with the Nanopatch, resulted in adjuvant dose sparing.

Hwee-Ing Ng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.